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A major goal of periodontal therapy is
restoration of the damaged tissues to
their original form and function and
requires regeneration of the destroyed
periodontal connective tissues through
formation of new cementum, new bone
and new attachment of new connective
tissue fibers (1–5). The observation that
enamel matrix proteins are involved in
the formation of cementum (6) led to
the proposal that these proteins may
have a beneficial effect in inducing
periodontal regeneration. This led to
the isolation of enamel matrix proteins
and their development for periodontal
regeneration. In recent years many
studies have confirmed that enamel
matrix proteins are capable of aiding
periodontal regeneration [see (7) for
review]. However, the exact mecha-
nisms involved in such induction are
still unclear.
Wound healing is a complex process
involving cell migration, cell attach-
ment to various components of the
extracellular matrix and cell prolifer-
ation. Many of these processes are
controlled by cytokines and growth
factors. While Emdogain (EMD) is
not strictly considered a growth factor
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Objective: The aim of this study was to evaluate the influence of Emdogain
(EMD) on cultured gingival fibroblasts, periodontal ligament fibroblasts and
dermal fibroblasts, using an in vitro model of wound healing.
Background: Enamel matrix derivative has been demonstrated to promote peri-
odontal regeneration. However, the precise mechanisms by which this agent acts
are still unclear.
Methods: The effect of EMD on proliferation of the cells was studied using
subconfluent cultures of gingival fibroblasts and periodontal ligament fibroblasts.
The cells were made quiescent overnight and then stimulated with various con-
centrations of EMD (10, 50, 100 and 150 lg/ml) for 24 h. Negative and positive
controls were cells cultured in media containing 0.2% and 10% fetal calf serum
(FCS). The DNA synthesis was measured by the cellular uptake of [3H]thymidine.
For in vitro wounding the cells were cultured, wounded and stimulated with 0.2%
FCS, 10% FCS and EMD at a concentration of 20 lg/ml. The percentage of
wound fill after treatment was measured after d 1, 4, 6, 12 and 16. The prolifer-
ation of cells was also calculated by the extent of incorporation of crystal violet.
Results: The results demonstrated that cells in vitro fill an empty space by a
combination of proliferation and cell migration. The most rapid closure of a
wound area occurred where both proliferation and migration can occur as was
seen when wounded cultures were maintained in 10% FCS or at a concentration of
20 lg/ml EMD which promoted proliferation.
Conclusions: Therefore, EMD appears to exert an influence on cells that is com-
patible with improved wound healing.
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it appears to possess a number of
properties that are growth factor-like.
The mode of action of EMD appears to
be through a matrix cell interaction
between theamelogeninaggregateof the
EMD and the cells of periodontal liga-
ment (8)14). Interestingly, enhanced
soft tissuewoundhealinghasbeennoted
following the use of EMD (15).
A previous study from our laborat-
ory has described an in vitro method to
analyse cell biological events associ-
ated with wound healing using cells
derived from the periodontium (16).
To date, only a few studies have been
carried out to study the effect of EMD
on such events using periodontal cells
(17, 18). Therefore this study, through
the use of an in vitro model of wound
healing, aimed to gain a better under-
standing about how EMD enhances
wound repair, particularly soft tissue
repair, by investigating its effect on the
proliferation and migration of human
periodontal cells.
Materials and methods
Fibroblast cultures
Following institutional ethics appro-
val, fibroblasts were obtained from
human gingiva and periodontal liga-
ment as described previously (16).
Tissue explants were cultured using
Dulbecco’s Modified Eagle’s medium
(DMEM) with 10% fetal calf serum
(FCS) supplemented with penicillin
(50 U/ml), streptomycin (50 lg/ml)
and fungizone (2.5 lg/ml). Cultures
were incubated at 37C in a humidified
atmosphere of 5% CO2 and 95% air.
The media were replaced every 2 or 3 d
until confluence was reached. The gin-
giva and periodontal ligament fibro-
blast used for this study were between
their 5th and 10th passage in culture.
The dermal fibroblasts were a very
kind gift from Dr Mark Hayes, Royal
Children Hospital, Brisbane, Australia.
These cell cultures had been obtained
from explants taken with consent from
patients undergoing facelift operations.
DNA synthesis
DNA synthesis was measured by the
uptake of [3H]thymidine. Human peri-
odontal ligament fibroblasts andhuman
gingival fibroblasts were seeded in
triplicate, into 24-well plates at an initial
density of 20,000 cells per well, and
allowed to attach and spread overnight
in DMEM containing 10% FCS.
The medium was then replaced with
500 ll/well of DMEM alone and incu-
bated for a further 48 h. This medium
was removed and replaced with either
control or test media, DMEM + 0.2%
FCS (negative control), DMEM +
10% FCS (positive control), and EMD
at concentrations of 10, 50, 100 and
150 lg/ml. LyophilizedEMDwasmade
to 1 mg/ml in 50 mM carbonate buffer
pH 9.0, 1 h prior to use (19). After 20 h
incubation in the test media,
[3H]thymidine was added to eachwell to
give a final concentration of 1lCi/ml.
The cells were incubated for a further
4 h, afterwhich themediawere removed
and the cells washed three times with
500 ll PBS. Cells were lysed by the ad-
dition of 1% SDS and the radioactivity
in the cell lysate was determined in a
Beckman LS-6000SC Liquid Scintil-
lation Counter (20).
In vitro wounding
Dermal fibroblasts, gingival fibroblasts
and periodontal ligament fibroblasts
were cultured in 4-well chamber plates,
and allowed to grow to confluence.
The cell layer was then wounded using
a sterilized silicon bung, which
removed the cells within a circular area
(8 mm diameter). After the wounding,
the media were removed and the wells
were washed twice with PBS. The cul-
tures were exposed to media containing
DMEM, supplements and either 0.2%
FCS, 10% FCS or 20 lg/ml EMD. A
low concentration of EMD was chosen
to avoid excessive build up of insoluble
components of EMD during the long-
term cultures. Media were replaced
every second day and incubation con-
tinued for 1, 4, 6, 12 and 16 d. One
plate (4 wells) was used for each time
and treatment. The cells were fixed in
glutaraldehyde 2% and later stained
with crystal violet (0.75% crystal
violet, 0.25% NaCl) (Fig. 1a,b).
Measurement of wound area
Digital images of the wounded cell
cultures were photographed (Olym-
pus Camedia C-3000) and the area
of the wound determined using NIH
Image Analysis System and
Software. The results were expressed
as percentage of the original wound
area.
Fig. 1. In vitro wound healing by gingival fibroblasts cells stained with crystal violet fol-
lowing treatment with 20 lg/ml EMD from d 0–16. (a) Edge of wound area immediately
after wounding (original magnification · 2.5). (b) View of the gingival fibroblasts filling the
wound area after 16 d of treatment with 20 g/ml EMD (original magnification · 2.5). (c–h)
show wound areas following treatment with 20 lg/ml EMD at d 0, 4, 6, 12 and 16 (original
magnification · 1). (c) Wound at d 0; (d) wound at d 1; (e) wound at d 4; (f) wound at d 6;
(g) wound at d 12; (h) wound at d 16.
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Cell proliferation
Once the photographs had been taken,
the incorporated dye was released from
the cells by the addition of 1 ml of 33%
acetic acid. Measurements of the absor-
bance at 570 nm allowed the increase in
cell number to be determined (21).
Statistical analyses
The values of each treatment group
were presented as a mean with the
standard deviation of quadruplicates.
The data were compared using the One
way ANOVA with Tukey–Kramer
multiple comparisons post-test. Using
InStat View 4.02 software (Abacus
Concepts, Inc., Berkley, CA, USA).
Results
DNA synthesis
The maximum proliferative response
of gingival fibroblasts and periodontal
ligament fibroblasts was noted with
EMD at concentrations of 50, 100 and
150 lg/ml with a highly significative
increase over 0.2% FCS controls
(P < 0.001). The effects of serum and
different concentrations of EMD on
gingival fibroblasts and periodontal
ligament fibroblasts on [3H]thymidine
incorporation into DNA are shown on
Fig. 2a, b.
For the gingival fibroblasts, EMD
resulted in a significant (P < 0.001)
increase in DNA synthesis compared
to the 0.2% and 10% FCS controls
when added at a concentration of
50 lg/ml and greater. At concentra-
tions less than 50 lg/ml there was no
significant effect on DNA synthesis by
the gingival fibroblasts.
A similar response was noted to the
periodontal ligament fibroblasts. At
concentrations of 50 lg/ml and greater
there was a significant (P < 0.001)
increase in thymidine uptake compared
to the 0.2% FCS controls and at con-
centrations of 100 lg/ml of EMD.
Responses at EMD concentrations of
10 and 50 lg/ml were not significant
compared to the 0.2% and 10% FCS
controls, respectively.
Fig. 2. [3H]Thymidine incorporation for (a) gingival fibroblasts and (b) periodontal ligament
fibroblasts. Quiescent subconfluent cultures were stimulated with various test media (0.2%
FCS, 10% FCS, EMD 10, 50, 100 and 150 lg/ml) for 24 h. [3H]thymidine was added for the
last 4 h of incubation. *Indicates a statistically significant difference between negative control
and test media P < 0.001.
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Wound healing
All cell lines showed a progressive
reduction in the wound area when
cultures were maintained in 10% FCS
(Fig. 3). By d 16, the remnant area of
the wound was 1.3% for the dermal
fibroblasts, 1.6% for the periodontal
ligament fibroblasts and 10.8% for the
gingival fibroblasts. When wounded
cultures were maintained in 20 lg/ml
of EMD, the wound area also
progressively reduced, although neither
the rate nor the extent of the wound
closure was as great as noted with the
10% FCS treatment. When wounded
cultures were maintained in 0.2% FCS
for 16 d, the wound area diminished,
but this was not as great as that noted
for the cells cultured in the presence of
either 10% FCS or EMD.
Cell proliferation
All cell types showed an increase in
cell number over the length of the
experiment when maintained in 10%
FCS. The level of this increase was
greatest for the gingival fibroblasts
(Fig. 4). In the presence of 20 lg/ml
EMD, the wounded gingival fibro-
blast cultures showed a significant
increase in cell number (threefold
increase after 6 d) compared with the
twofold increase in the presence of
0.2% FCS.
By contrast, the wounded perio-
dontal ligament fibroblast cultures
showed no significant increase in cell
number when maintained in either
0.2% FCS or 20 lg/ml EMD. The
wounded dermal fibroblasts did not
increase in cell number when main-
tained in 0.2% FCS, and only
increased slightly in cell number in the
Fig. 3. Percentage of wound area closure following different treatments during d 1, 4, 6, 12 and 16 for (a) gingival fibroblasts, (b) periodontal
ligament fibroblasts and (c) dermal fibroblasts. *Indicates a statistically significant difference (P < 0.01) in wound closure compared to d 0.
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presence of 20 lg/ml EMD (1.3-fold
increase) (Fig. 4a–c).
Discussion
EMD has been shown to stimulate
periodontal fibroblast proliferation in
the short term at concentrations of
50 lg/ml, 100 lg/ml and 150 lg/ml,
but not at 10 lg/ml. An EMD con-
centration of 20 lg/ml regularly
replenished in a long-term culture was
chosen for the in vitro wounding to
minimize the effects of prolonged
deposition of insoluble components of
the EMD. At this concentration EMD
was also determined to be at the
lowest effective concentration with
regards to its effect on fibroblast
proliferation as judged by thymidine
uptake. It could be expected that
these conditions would promote
proliferation if the mitotic component
of EMD accumulated during the
length of the assay.
In vitro wounding of cell cultures
resulted in various degrees of wound
closure depending on the type of cell
studied and the media in which the
cultures were maintained. EMD at
20 lg/ml was almost as effective at
promoting wound closure as 10% FCS
for all cells types. Indeed, some level of
Fig. 4. Changes in cell number during in vitro wound healing. (a) gingival fibroblasts, (b) periodontal ligament fibroblasts and (c) dermal
fibroblasts. The fold increase in cell number was determined relative to the number of cells present at d 1. *Indicates a statistically significant
difference (P < 0.01) in cell numbers compared to those recorded at d 0.
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wound closure was seen in all cell types
when cultures were maintained in 0.2%
FCS, but this wound closure was not
maintained over the full 16 d of this
experiment, possibly reflecting the loss
of viability of the fibroblasts cul-
tured for long-term in reduced serum
conditions. A previous study using a
different wound-healing model has
described a similar effect of EMD on
wound closure responses of periodon-
tal ligament fibroblasts and gingival
fibroblasts (18, 22). The main differ-
ence in the models is the relative area
of wound in the cultures. The model
used in our laboratory (16) created a
relatively large area of wound, which
permits longer-term observations to be
made.
Continuous replenishment of EMD
at low concentration was conducive to
the proliferation of gingival fibroblasts,
but not to the periodontal ligament
fibroblasts or the dermal fibroblasts.
This resulted in a more rapid and
complete wound closure for gingival
fibroblasts than for the periodontal
ligament fibroblasts or dermal fibro-
blasts. This is in contrast to other
studies, which have shown a marked
influence on periodontal ligament
fibroblast proliferation after 7–10 d
(16). Whether this reflects the signifi-
cant variability and heterogeneity of
primary periodontal ligament fibro-
blast cultures (23) remains to be
established.
In conclusion the results from this
study indicate that, in vitro, the most
rapid closure of a wound area occurs
when both proliferation and migration
can occur as was seen when wounded
cultures were maintained in 10% FCS
or at a concentration of 20 lg/ml
EMD. Such findings may help, in part,
to explain the clinical results noted
following the use of Emdogain. It has
been reported that in addition to pro-
moting periodontal regeneration,
Emdogain also seems to promote rapid
soft tissue repair. The results from this
study indicate that gingival fibroblasts
respond vigorously to exposure to
EMD and this could account for the
excellent gingival responses noted fol-
lowing its use. Although the perio-
dontal ligament fibroblasts in our
study did not respond as much as the
gingival cells this is not inconsistent
with our understanding of regeneration
whereby matrix synthesis and prolifer-
ation are often mutually exclusive.
Thus, as has been reported elsewhere,
EMD may well enhance matrix syn-
thesis by periodontal ligament cells
thereby permitting them to undertake
the processes necessary for recon-
struction of the periodontal tissues
without the complicating factor of
going through unnecessary replicative
processes.
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